[1]
G. J. Weiss, “Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome”, Dermatol Reports, vol. 3, no. 3, p. e55, Dec. 2011.